Pedrazzoli S, Sperti C, Pasquali C
Department of Medical and Surgical Sciences, Surgical Semeiotics, University of Padova, Italy.
Pancreas. 2001 Oct;23(3):309-15. doi: 10.1097/00006676-200110000-00013.
Duodenum-preserving pancreatic head resection (DPPHR) has been safely performed in patients with chronic pancreatitis. The procedure has rarely been used to remove benign or borderline lesions of the head of the pancreas.
To review our experience with 13 patients who underwent DPPHR and to review reports in the literature on the same subject.
From October 1991 to September 2000, 13 patients underwent DPPHR to resect endocrine pancreatic tumors (n = 4), beta cell hyperplasia (n = 1), pancreatic pseudocysts (n = 2), serous cystadenomas (n = 3), congenital (n = 1) and choledochal (n = 1) cysts, and intraductal papillary mucinous tumor (n = 1). The Kocher maneuver was performed in seven patients (group 1) and avoided in six (group 2). Type 1, 2, and 3 DPPHR were defined depending on the amount of pancreatic tissue left at the inner surface of the duodenum. Ten patients underwent evaluation that included an oral glucose tolerance test and exocrine pancreatic function test.
The mortality rate was zero; the complication rate was 69%. Patients in whom the Kocher maneuver was not performed (group 2) experienced fewer complications, shorter stay on nasogastric tube and abdominal drain(s), and earlier water intake and discharge. Type of DPPHR did not influence the postoperative course. One patient died 3 months after surgery of unrelated disease. Twelve patients were alive and well 2 months to 8 years after surgery.
DPPHR is a low-risk procedure in patients with benign or borderline noninflammatory lesions of the head of the pancreas in whom pylorus-preserving pancreaticoduodenectomy is otherwise indicated. Whenever possible, the Kocher maneuver should be avoided.
保留十二指肠的胰头切除术(DPPHR)已在慢性胰腺炎患者中安全实施。该手术很少用于切除胰腺头部的良性或交界性病变。
回顾我们对13例行DPPHR患者的经验,并复习文献中关于同一主题的报道。
1991年10月至2000年9月,13例患者接受DPPHR以切除胰腺内分泌肿瘤(n = 4)、β细胞增生(n = 1)、胰腺假性囊肿(n = 2)、浆液性囊腺瘤(n = 3)、先天性囊肿(n = 1)和胆总管囊肿(n = 1)以及导管内乳头状黏液性肿瘤(n = 1)。7例患者(第1组)进行了 Kocher 手法操作,6例(第2组)未进行。根据十二指肠内表面剩余胰腺组织的量定义1型、2型和3型DPPHR。10例患者接受了包括口服葡萄糖耐量试验和胰腺外分泌功能试验在内的评估。
死亡率为零;并发症发生率为69%。未进行Kocher手法操作的患者(第2组)并发症较少,鼻胃管和腹腔引流管留置时间较短,进水和出院较早。DPPHR的类型不影响术后病程。1例患者术后3个月死于无关疾病。12例患者术后2个月至8年存活且状况良好。
对于胰腺头部良性或交界性非炎性病变且原本需行保留幽门的胰十二指肠切除术的患者,DPPHR是一种低风险手术。只要有可能,应避免进行Kocher手法操作。